How Has The Antibiotic Resistance Market Size Evolved In Recent Years?
The antibiotic resistance market has seen considerable growth due to a variety of factors.
•In recent times, the size of the antibiotic resistance market has witnessed robust growth. It is expected to increase from $12.21 billion in 2024 to $12.89 billion in 2025, boasting a compound annual growth rate (CAGR) of 5.6%.
The substantial growth seen in the previous years is due to the dearth of new antibiotics, excessive and inappropriate use of antimicrobials in humans, animals, and plants, highly polluted waste effluents, low immunization rates, and inadequate diagnostic tools.
What Is The Projected Growth Of The Antibiotic Resistance Market?
The antibiotic resistance market is expected to maintain its strong growth trajectory in upcoming years.
• The market size for antibiotic resistance is anticipated to witness substantial expansion in the upcoming years. The market is projected to reach $16.97 billion by 2029, growing at a compound annual growth rate (CAGR) of 7.1%.
Factors expected to contribute to this growth during the projection period include the initiation of incomplete treatments, increased globalization and travel, inadequate infection prevention and control practices, self-medication trends, cross-species transmission, and high population density. Key trends to watch for during this period include the advancements in drug delivery technology, global partnerships for surveillance, the increasing influence of artificial intelligence, and a surge in breakthrough therapies.
What Are The Primary Growth Drivers In The Antibiotic Resistance Market?
The antibiotic-resistance market is predicted to expand due to the increasing occurrence of drug-resistant infections. These are illnesses caused by resistant bacteria, making them tougher or even impossible to treat. Antimicrobial resistance drugs aid in effectively treating various drug-resistant infections, improving antibiotic treatment results for both targeted and non-targeted pathogens, based on the specifics of resistance mechanisms and the structure of microbial community interaction. For example, a UK Health Security Agency report from November 2023 revealed that around 58,224 people in England had an antibiotic-resistant infection in 2022, a 4% rise from the 55,792 cases reported in the previous year. Consequently, it's the prevalence of drug-resistant infections that is fueling the antibiotic resistance market's growth.
What Is The Segmentation Of The Global Antibiotic Resistance Market?
The antibiotic resistance market covered in this report is segmented –
1) By Drug Class: Beta Lactum Antibiotic, Cephalosporins, Quinolones Antibiotics, Macrolide Antibiotics, Tetracyclines, Oxazolidinones, Other Drug Classes
2) By Pathogen: Staphylococcus Aureus, Staphylococcus Pneumonia, Neisseria Gonorrhoeae, Enterococcus Faecium, Escherichia Coli, Klebsiella Pneumonia, Shigella, Clostridium Difficile, Other Pathogens
3) By Disease Type: Urinary Tract Infection, Intra-Abdominal Infection, Blood Stream infections, Clostridium Difficile Infections, Other Disease Types
4) By Mechanism Of Action: Protein Synthesis Inhibitors, Cell Wall Synthesis Inhibitors, RNA Synthesis Inhibitors, DNA Synthesis Inhibitors, Other Mechanism Of Actions
5) By End Users: Hospitals, Homecare, Specialty Clinics, Other End-users
Subsegments:
1) By Beta Lactam Antibiotics: Penicillins, Cephalosporins, Carbapenems, Monobactams
2) By Cephalosporins: First-generation, Second-generation, Third-generation, Fourth-generation
3) By Quinolones Antibiotics: Fluoroquinolones, Other Quinolones
4) By Macrolide Antibiotics: Erythromycin, Azithromycin, Clarithromycin
5) By Tetracyclines: Doxycycline, Minocycline, Tetracycline
6) By Oxazolidinones: Linezolid, Tedizolid
7) By Other Drug Classes: Glycopeptides, Lipopeptides, Streptogramins, Polymyxins
Pre-Book The Antibiotic Resistance Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Emerging Trends Are Shaping The Antibiotic Resistance Market Landscape?
The primary trend gaining momentum in the antibiotic resistance market is product innovation. Major firms in the sector are concentrating on developing cutting-edge products to enhance their market standing. For example, Alkem Laboratories Limited, a pharmaceutical company based in India, launched Zidavi, a groundbreaking antibiotic for multi-drug resistant (MDR) infections, in January 2023. Zidavi aims to deliver availability, affordability, and accessibility while saving lives of critically sick patients. It's a unique blend of ceftazidime and avibactam that can treat MDR gram-negative pathogen infections. The product is available for infusion in a sterile powder concentrate for reconstitution containing 2 g ceftazidime equivalent to ceftazidime pentahydrate and 0.5 g avibactam equivalent to avibactam sodium in each single-dose vial. Moreover, it provides an effective alternative for treating hospital-acquired pneumonia (HAP) and serious intra-abdominal infections (IAIs) that are resistant to meropenem and colistin.
Who Are the Key Players in the Antibiotic Resistance Market?
Major companies operating in the antibiotic resistance market include:
• Pfizer Inc.
• Johnson and Johnson
• F. Hoffmann-La Roche Ltd
• AbbVie Inc.
• Novartis AG
• Merck and Co. Inc.
• Bristol-Myers Squibb
• Sanofi S.A.
• Thermo Fisher Scientific Inc
• AstraZeneca
• GlaxoSmithKline Plc
• Eli Lilly and Company
• Boehringer Ingelheim International GmbH
• Astellas Pharma
• Daiichi Sankyo
• Chugai Pharmaceutical Co. Ltd.
• Teva Pharmaceutical Industries Ltd.
• Bio-Rad Laboratories Inc
• Eppendorf Corporation
• Takara Bio Inc
• Wockhardt Ltd.
• Paratek Pharmaceuticals Inc.
• Basilea Pharmaceutica Ltd.
• Theravance Biopharma Inc.
• Nabriva Therapeutics Plc
• Seres Therapeutics Inc
• Armata Pharmaceuticals Inc.
What are the Regional Insights into the Antibiotic Resistance Market?
North America was the largest region in the antibiotic resistance market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antibiotic resistance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
